Vertex Pharmaceuticals Incorporated has announced that Casgevy, a CRISPR/Cas9 gene-edited cell therapy, has been approved by the US Food and Drug Administration (FDA) for the treatment of transfusion-dependent beta thalassemia (TDT) in patients...
GlaxoSmithKline Pharmaceuticals Limited initiated a multichannel campaign to raise awareness about immunizations, which give important protection to children aged one to two years. The Indian Academy of Paediatrics (IAP) recommends seven...
Sun Pharmaceutical Industries Limited of India has announced that it will purchase all of Taro Pharmaceutical Industries' outstanding shares for $43 per share in cash, effectively assuming complete control of the company. Pharma's offer amounts...
Sun Pharma announced a collaboration with Bayer to market a medication for the treatment of chronic kidney disease and other conditions. Under the terms of the deal, Bayer granted Sun Pharma non-exclusive rights to market and distribute a second...
Roche announced that the European Commission has granted marketing authorisation for Tecentriq SC (atezolizumab), the European Union (EU)’s first PD-(L) cancer immunotherapy for subcutaneous (under the skin) injection. Last year, more than 38,000...
Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, and the Japanese Foundation for Cancer Research (JFCR), the first and leading non-profit cancer...
The World Health Organization (WHO) has approved Corbevax, a Covid vaccine created by Hyderabad-based vaccine producer Biological E. Corbevax, India's first indigenously manufactured Covid-19 vaccine based on a protein subunit platform, is part...
AM-Pharma B.V. stated that the first patients have been treated in a Phase 2 clinical trial assessing the company's proprietary recombinant alkaline phosphatase, ilofotase alfa, as a preventive treatment for cardiac surgery-associated renal damage...
Drug Farm, a clinical-stage biopharmaceutical company announced that the US Food and Drug Administration (FDA) has granted Rare Paediatric Disease (RPD) Designation for the company’s alpha-kinase 1 (ALPK1) inhibitor, DF-003, to treat patients with...
To improve the provision of cancer services to Alabama communities, Clearview Cancer Institute and OneOncology, the nation's fastest-growing platform for independent oncology practices, announced the completion of their agreement...
, CDSCO.jpg)
